Farnesoid X receptor (FXR): Structures and ligands (vol 19, pg 2148, 2021)

被引：0
|
作者：
Jiang, Longying [1 ,2 ]
Zhang, Huajun [2 ]
Xiao, Desheng [1 ]
Wei, Hudie [1 ,2 ]
Chen, Yongheng [1 ,2 ]
机构：
[1] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Dept Pathol,NHC Key Lab Canc Prote,Lab Struct Biol, Changsha 410008, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Dept Oncol,NHC Key Lab Canc Prote,Lab Struct Biol, Changsha 410008, Hunan, Peoples R China
来源：
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL | 2022年 / 20卷
关键词：
D O I：
10.1016/j.csbj.2022.02.0292001-0370
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1227 / 1228
页数：2
相关论文
共 50 条
  • [31] Farnesoid X receptor (FXR) as a novel target in vascular smooth muscle cells
    Bishop-Bailey, D
    Walsh, DT
    Warner, TD
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U30 - U30
  • [32] Conformationally constrained farnesoid X receptor (FXR) agonists: Alternative replacements of the stilbene
    Akwabi-Ameyaw, Adwoa
    Caravella, Justin A.
    Chen, Lihong
    Creech, Katrina L.
    Deaton, David N.
    Madauss, Kevin P.
    Marr, Harry B.
    Miller, Aaron B.
    Navas, Frank, III
    Parks, Derek J.
    Spearing, Paul K.
    Todd, Dan
    Williams, Shawn P.
    Wisely, Bruce
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (20) : 6154 - 6160
  • [33] Activation of Farnesoid X Receptor (FXR) Reduces Atherosclerosis in LDLRKO and apoEKO Mice
    Hartman, Helen B.
    Harnish, Douglas C.
    Evans, Mark J.
    CIRCULATION, 2008, 118 (18) : S566 - S566
  • [34] The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis
    Cariou, B.
    DIABETES & METABOLISM, 2008, 34 (06) : 685 - 691
  • [35] Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice
    Zhang, Xiaoyan
    Huang, Shizheng
    Gao, Min
    Liu, Jia
    Jia, Xiao
    Han, Qifei
    Zheng, Senfeng
    Miao, Yifei
    Li, Shuo
    Weng, Haoyu
    Xia, Xuan
    Du, Shengnan
    Wu, Wanfu
    Gustafsson, Jan-Ake
    Guan, Youfei
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (06) : 2277 - 2282
  • [36] Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene
    Bass, Jonathan Y.
    Caravella, Justin A.
    Chen, Lihong
    Creech, Katrina L.
    Deaton, David N.
    Madauss, Kevin P.
    Marr, Harry B.
    McFadyen, Robert B.
    Miller, Aaron B.
    Mills, Wendy Y.
    Navas, Frank, III
    Parks, Derek J.
    Smalley, Terrence L., Jr.
    Spearing, Paul K.
    Todd, Dan
    Williams, Shawn P.
    Wisely, G. Bruce
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (04) : 1206 - 1213
  • [37] Medicinal Chemistry of Farnesoid X Receptor (FXR) Modulators: The-State-of-the-Art
    Marinozzi, Maura
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (19) : 2127 - 2128
  • [38] Differential roles of farnesoid X receptor (FXR) in modulating apoptosis in cancer cells
    Girisa, Sosmitha
    Rana, Varsha
    Parama, Dey
    Dutta, Uma
    Kunnumakkara, Ajaikumar B.
    APOPTOSIS IN HEALTH AND DISEASE, PT B, 2021, 126 : 63 - 90
  • [39] a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation
    Renga, Barbara
    Mencarelli, Andrea
    D'Amore, Claudio
    Zampella, Angela
    Distrutti, Eleonora
    Fiorucci, Stefano
    GASTROENTEROLOGY, 2012, 142 (05) : S878 - S878
  • [40] The farnesoid x receptor (FXR) antagonizes oxidized LDL receptor, LOX-1, activation
    Harnish, Douglas
    Hahn, Ashleigh
    Hartman, Helen
    Huard, Christine
    Martinez, Robert
    Mahaney, Paige
    Evans, Mark
    Zhang, Songwen
    CIRCULATION, 2007, 116 (16) : 161 - 161
12345